Skip to main content

Table 2 DECT parameters and thyroid function indicators in PTC patients

From: Prediction of ipsilateral lateral cervical lymph node metastasis in papillary thyroid carcinoma: a combined dual-energy CT and thyroid function indicators study

 

Total

(n = 406)

LLNM (−)

(n = 278)

LLNM (+)

(n = 128)

P value

Tg (ng/mL)

25.54 (12.08–134.12)

16.28 (9.55–35.46)

149.26 (104.05–182.76)

< .0001

Anti-Tg (IU/mL)

11.5 (7.70–110.02)

7.70 (7.70–19.21)

117.70 (13.50–166.40)

< .0001

Anti-TPO (IU/mL)

7.01 (3.31–18.12)

5.24 (1.52–10.70)

19.94 (3.70–156.56)

< .0001

Volume (cm3)

0.38 (0.14–1.44)

0.18 (0.01–0.70)

0.72 (0.18–2.76)

.000

IC IAP (mg/mL)

3.0 (2.6–3.7)

2.8 (2.4–3.2)

3.8 (3.3–4.5)

.000

IC IVP (mg/mL)

2.8 (2.4–3.3)

2.6 (2.2–3.1)

3.3 (2.8–4.1)

.000

  1. Note: Mann-Whitney U test, median (IQR)
  2. DECT Dual-energy computed tomography, PTC Papillary thyroid carcinoma, LLNM Lateral cervical lymph node metastasis, IC Iodine concentration, IAP In the arterial phase, IVP In the venous phase, IQR Interquartile range